AZD2927

DRUG2 trials

Sponsors

AstraZeneca

Conditions

ArrhythmiaHealthy

Phase 1

A Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD2927 in Healthy Male Volunteers

CompletedNCT01264250

AstraZenecaHealthy

Start: 2011-01-31End: 2011-05-31Target: 48Updated: 2011-05-24

Phase 2

A Multi-centre Study Comparing the Effects of AZD2927 and Placebo on the Electrical Activity in the Heart in Patients

CompletedNCT01396226

AstraZenecaArrhythmia

Start: 2011-09-30End: 2012-01-31Updated: 2012-11-27